Novo Nordisk A/S (NVO)

Novo Nordisk Income Statement

Financials in millions DKK. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	232,261	176,954	140,800	126,946	122,021
Revenue Growth (YoY)	31.26%	25.68%	10.91%	4.04%	9.11%
Cost of Revenue	35,765	28,448	23,658	20,932	20,088
Gross Profit	196,496	148,506	117,142	106,014	101,933
Selling, General & Admin	61,598	50,684	41,058	36,886	35,830
Research & Development	32,443	24,047	17,772	15,462	14,220
Other Operating Expenses	-119	-1,034	-332	-460	-600
Operating Expenses	93,922	73,697	58,498	51,888	49,450
Operating Income	102,574	74,809	58,644	54,126	52,483
Interest Expense / Income	378	289	0	0	0
Other Expense / Income	-2,478	5,458	-436	996	3,930
Pretax Income	104,674	69,062	59,080	53,130	48,553
Income Tax	20,991	13,537	11,323	10,992	9,602
Net Income	83,683	55,525	47,757	42,138	38,951
Net Income Growth	50.71%	16.27%	13.33%	8.18%	0.84%
Shares Outstanding (Basic)	4,560	4,523	4,584	4,716	4,900
Shares Change	0.81%	-1.32%	-2.80%	-3.76%	-2.00%
EPS (Basic)	18.67	12.26	10.40	9.03	8.21
EPS (Diluted)	18.62	12.22	10.37	9.01	8.19
EPS Growth	52.37%	17.84%	15.16%	9.95%	2.82%
Free Cash Flow	83,102	66,741	48,665	46,133	37,854
Free Cash Flow Per Share	18.22	14.76	10.62	9.78	7.72
Dividend Per Share	1.036	0.810	0.753	0.652	0.508
Dividend Growth	27.90%	7.57%	15.49%	28.35%	-2.87%
Gross Margin	84.60%	83.92%	83.20%	83.51%	83.54%
Operating Margin	44.16%	42.28%	41.65%	42.64%	43.01%
Profit Margin	36.03%	31.38%	33.92%	33.19%	31.92%
Free Cash Flow Margin	35.78%	37.72%	34.56%	36.34%	31.02%
Effective Tax Rate	20.05%	19.60%	19.17%	20.69%	19.78%
EBITDA	114,465	76,713	65,105	58,883	54,214
EBITDA Margin	49.28%	43.35%	46.24%	46.38%	44.43%
Depreciation & Amortization	9,413	7,362	6,025	5,753	5,661
EBIT	105,052	69,351	59,080	53,130	48,553
EBIT Margin	45.23%	39.19%	41.96%	41.85%	39.79%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).